Kiniksa Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing therapies for patients suffering from debilitating diseases with significant unmet medical need. The company's pipeline includes several product candidates targeting autoinflammatory and autoimmune diseases. Kiniksa Pharmaceuticals was founded in 2015 and is headquartered in Lexington, Massachusetts. The company is committed to advancing science and improving the lives of patients through innovative research and development.